UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
The association between detected drug resistance mutations and CD4(+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Schultze A, Paredes R, Sabin C, Phillips AN, Pillay D, Mackie N, Castagna A, Chadwick D, Falconer K, Geretti AM, Post FA, Hill T, Kirk O, Pozniak A, Nelson M, Tostevin A, Dunn D, Lundgren J, Cozzi-Lepri A
  • Publication date:
    19/06/2017
  • Journal:
    Antiviral therapy
  • Medium:
    Print-Electronic
  • Print ISSN:
    1359-6535
  • Language:
    eng
  • Addresses:
    Department of Infection and Population Health, UCL, London, UK.
Abstract
To analyse the effect of drug resistance mutations (DRM) on CD4 cell trends in HIV-positive people maintained on virologically failing antiretroviral therapy (ART).Individuals from two large cohorts experiencing virological failure (VF) while maintained on ART with >1 CD4 count and >1 resistance test were included. CD4 cell slopes were estimated using linear mixed models. Principal component analysis (PCA) was used to assess the effect of clusters of mutations, defined using extracted component based scores from the PCA, on CD4 cell decline.5,357 individuals contributing 7,661 VF episodes were included: any DRM were detected in 88.8% of episodes. After adjustment, CD4 counts declined less steeply during episodes where DRM were detected compared to episodes with no DRM (difference=28 cells/mm(3)/year, 95%CI=18-39, p<0.001). Among individuals with at least one DRM, we found evidence that any nucleoside/nucleotide reverse-transcriptase inhibitor (NRTI) resistance, the reverse transcriptase (RT) mutations M184V, D67N and T215Y as well as the protease mutations V82A and I54V were associated with reduced CD4 cell declines. The detection of any non-nucleoside reverse-transcriptase inhibitor (NNRTI) resistance, the RT mutations V179D and L74V were associated with steeper CD4 cell declines. The presence of some mutation patterns similar to the clusters identified by the PCA also affected the CD4 cell decline.Detection of resistance and of certain DRM during VF of ART has a small but significant favourable effect on CD4 cell decline.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers Show More
Author
Infection & Population Health
Author
MRC Clinical Trials Unit at UCL
Author
Infection & Population Health
Author
Div of Infection & Immunity
Author
Infection & Population Health
Author
Institute for Global Health
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by